Belgium
# |
Name |
Net Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 378.59 M
|
Dec. 31, 2023 | USD 195.15 | -0.39% |
|
Belgium |
|
2 |
USD 233.66 M
|
Dec. 31, 2023 | USD 24.20 | -0.41% |
|
Belgium |
|
3 |
USD 196.14 M
|
Dec. 31, 2023 | USD 19.13 | -0.63% |
|
Belgium |
|
4 |
USD 120.86 M
|
Dec. 31, 2023 | USD 19.81 | 0.71% |
|
Belgium |
|
5 |
USD 97.30 M
|
Dec. 31, 2023 | USD 150.68 | -0.48% |
|
Belgium |
|
6 |
USD -10.06 M
|
Dec. 31, 2023 | USD 13.71 | -0.44% |
|
Belgium |
|
7 |
USD -22.64 M
|
Dec. 31, 2023 | USD 3.28 | -5.91% |
|
Belgium |
The Biotechnology company in Belgium with the highest Net Income is UCB SA (Brussels Stock Exchange: UCB.BR) at USD 378.59 M.
The Biotechnology company in Belgium with the lowest Net Income is Biotalys NV (Brussels Stock Exchange: BTLS.BR) at USD -22.64 M.
The top 10 Biotechnology companies in Belgium by Net Income are UCB SA, Galapagos NV, Azelis Group NV, Tessenderlo Group NV, Financière de Tubize SA, Ion Beam Applications SA and Biotalys NV.
The bottom 10 Biotechnology companies in Belgium by Net Income are Biotalys NV, Ion Beam Applications SA, Financière de Tubize SA, Tessenderlo Group NV, Azelis Group NV, Galapagos NV and UCB SA.